Musculoskeletal Diseases

All Conditions

Neoplasms

Skin and Connective Tissue Diseases

Nervous System Diseases

Contracture

Dupuytren Contracture

Joint Diseases

Muscular Diseases

Fibroma

Neoplasms, Fibrous Tissue

Neoplasms, Connective Tissue

Neoplasms, Connective and Soft Tissue

Neoplasms by Histologic Type

Connective Tissue Diseases

1: xiapex: 0,58 mg clostridium histolyticum administered in the dupuytrens cord as discribed in producers manual

percutaneous needle fasciotomi is performed at affected cords

xiapex

percutaneous needle fasciotomy

hallgeir bratberg, MD

The purpose of this study is to investigate whether percutaneous needle fasciotomy is as effective for treating Dupuytrens contracture as Xiapex. Immidiate treatment effect is to be investigated, as iskontracture size after 5 years. Contracture size after one and three years, and subjective hand function is also to be investigated.

Prospective randomized study between Percutanous Needle Fasciotomy and Xiapex for Dupuytrens contracture.

A total of 50 patiens are to be randomized to eighter percutaneous needle fasciotomy or Xiapex treatment.

The patients randomized to xiapex treatment are treated as described in the product manual. Extentin treatment after one day.

The patients randomized to percutaneous needle fasciotomy are treated with the cutting teqnique: A littel quaddle local anestesia (xylocaine with adrenaline) is to be injected subcutant over the cord. After thet we use a 19G needle to cut the cord sufficient number sites to extend the finger.

The patients will be follwed up at 3 weeks, 3 months, 1 year, 3 years and 5 years. Investigators record contracture size, quicq-DASH, pain (VAS) and hand disability (VAS) pretreatment and at all controlls. At 3 weeks investigators register procedure complain. Side effects and complications, and advere effects are also to be investigated.

Our hypothesis is that it is no difference between the two methods in regard of contracture size after five years.

Inclution criteria: Symptomatic primary Dupuytrens contracture with palpable cord in one to three fingers, involving MCP, and total contracture size is over 30 degrees. Patient age over 18 years.

Exclution criteria:

Previously treated Dupuytrens contracture in the same hand more than tree affected fingers we will not include thumbs Other symptomatic injury or disease influencingf hand function ASA\>3 Expected lifetime less than five years tetracycline treatment within two weeks pregnancy nursing allergy to clostridium histolyticum concmittent other clinical trial

Prospective Randomized Trial Between Needle Fasciotomy and Xiapex for Dupuytrens Contracture

Prospektiv Randomisert Sammenlikning Mellom Percutan nålefasciotomi og Xiapex for Dupuytrens Kontraktur

contracture size mesured in degrees in each finger joint

Quick-DASH functional score measured in points.

Contracture size mesured in degrees in each finger joint

Oslo University Hospital

Injection of collagenase obtained from Clostridium Histolyticum in contracture string

Xiapex

Percutaneous needle fasciotomy ad modum Lermusiaux and Debeyre

Percutaneous needle fasciotomy

Jeppe Lange, M.D.

Comparing injectable collagenase and percutaneous needle fasciotomy for Dupuytren's contracture affecting proximal interphalangeal joints. An open label, medico-independent randomized controlled trial.

Injectable Collagenase and Percutaneous Needle Fasciotomy for Dupuytren's Contracture

Comparing Injectable Collagenase (CI) and Percutaneous Needle Fasciotomy (PNF) for Dupuytren's Contracture (DC) Affecting Proximal Interphalangeal Joints (PIP). A Randomised Controlled Trial

Clinical improvement is defined as a contracture reduction 50% or more from baseline.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Prospective Randomized Trial Between Needle Fasciotomy and Xiapex for Dupuytrens Contracture	NCT02476461	Dupuytrens Cont...	xiapex percutaneous ne...	18 Years -	Oslo University Hospital
Injectable Collagenase and Percutaneous Needle Fasciotomy for Dupuytren's Contracture	NCT01538017	Dupuytrens Cont...	Xiapex Percutaneous ne...	18 Years - 99 Years	Regionshospitalet Silkeborg
Injectable Collagenase and Percutaneous Needle Fasciotomy for Dupuytren's Contracture	NCT01538017	Dupuytrens Cont...	Xiapex Percutaneous ne...	18 Years - 99 Years	Regionshospitalet Silkeborg
Prospective Randomized Trial Between Needle Fasciotomy and Xiapex for Dupuytrens Contracture	NCT02476461	Dupuytrens Cont...	xiapex percutaneous ne...	18 Years -	Oslo University Hospital

Spots Global Cancer Trial Database for dupuytrens contracture